Drugs / bacitracin polymyxin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03199911 | Oct 2017 → Nov 2019 | drug allergy, eyelid disorder, poisoning, skin cancer | University of California, San Francisco | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bacitracin polymyxin | “If the patient cannot obtain either (e.g. lack of availability at the pharmacy), bacitracin polymyxin will be prescribed.” NCT03199911 ↗ |